Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
ERYTECH Pharma S.A. ERYP.PA
$1.03
+$0.01 (1.18%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
31512358.00000000
-
week52high
1.48
-
week52low
0.29
-
Revenue
0
-
P/E TTM
119
-
Beta
2.24923600
-
EPS
-0.01000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 14:00
Описание компании
ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target methionine cancers. The company was incorporated in 2004 and is headquartered in Lyon, France.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Cowen & Co. | Outperform | 05 дек 2017 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии